In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds

ABSTRACT The antibacterial activity of 22 thiolato-bridged dinuclear ruthenium(II)-arene compounds was assessed in vitro against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. None of the compounds efficiently inhibited the growth of the three E. coli strains tested, and only...

Full description

Bibliographic Details
Main Authors: Quentin Bugnon, Camilo Melendez, Oksana Desiatkina, Louis Fayolles de Chaptes, Isabelle Holzer, Emilia Păunescu, Markus Hilty, Julien Furrer
Format: Article
Language:English
Published: American Society for Microbiology 2023-12-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00954-23
_version_ 1797393617791221760
author Quentin Bugnon
Camilo Melendez
Oksana Desiatkina
Louis Fayolles de Chaptes
Isabelle Holzer
Emilia Păunescu
Markus Hilty
Julien Furrer
author_facet Quentin Bugnon
Camilo Melendez
Oksana Desiatkina
Louis Fayolles de Chaptes
Isabelle Holzer
Emilia Păunescu
Markus Hilty
Julien Furrer
author_sort Quentin Bugnon
collection DOAJ
description ABSTRACT The antibacterial activity of 22 thiolato-bridged dinuclear ruthenium(II)-arene compounds was assessed in vitro against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. None of the compounds efficiently inhibited the growth of the three E. coli strains tested, and only compound 5 exhibited a medium activity against this bacterium [MIC (minimum inhibitory concentration) of 25 µM]. However, a significant antibacterial activity was observed against S. pneumoniae, with MIC values ranging from 1.3 to 2.6 µM for compounds 1–3, 5, and 6. Similarly, compounds 2, 5–7, and 20–22 had MIC values ranging from 2.5 to 5 µM against S. aureus. The tested diruthenium compounds have a bactericidal effect significantly faster than that of penicillin. Fluorescence microscopy assays performed on S. aureus using the BODIPY-tagged diruthenium complex 15 showed that this type of metal compound enters the bacteria and does not accumulate in the cell wall of gram-positive bacteria. Cellular internalization was further confirmed by inductively coupled plasma mass spectrometry experiments. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appears to significantly influence the antibacterial activity. Thus, if overall a decrease of the bactericidal effect with the increase of compounds’ molecular weight is observed, however, the complexes bearing larger benzo-fused lactam substituents had low MIC values. This first antibacterial activity screening demonstrated that the thiolato-diruthenium compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies. IMPORTANCE The in vitro assessment of diruthenium(II)-arene compounds against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus showed a significant antibacterial activity of some compounds against S. pneumoniae, with minimum inhibitory concentration (MIC) values ranging from 1.3 to 2.6 µM, and a medium activity against E. coli, with MIC of 25 µM. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appear to significantly influence the antibacterial activity. Fluorescence microscopy showed that these ruthenium compounds enter the bacteria and do not accumulate in the cell wall of gram-positive bacteria. These diruthenium(II)-arene compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies, especially the compounds bearing larger benzo-fused lactam substituents.
first_indexed 2024-03-09T00:05:11Z
format Article
id doaj.art-9c1d98f75af44e11bccb57734ac7d10e
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-09T00:05:11Z
publishDate 2023-12-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-9c1d98f75af44e11bccb57734ac7d10e2023-12-12T13:17:21ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-12-0111610.1128/spectrum.00954-23In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compoundsQuentin Bugnon0Camilo Melendez1Oksana Desiatkina2Louis Fayolles de Chaptes3Isabelle Holzer4Emilia Păunescu5Markus Hilty6Julien Furrer7Department of Medicine, Institute for Infectious Diseases, University of Bern , Bern, SwitzerlandDepartment of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern , Bern, SwitzerlandDepartment of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern , Bern, SwitzerlandDepartment of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern , Bern, SwitzerlandDepartment of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern , Bern, SwitzerlandDepartment of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern , Bern, SwitzerlandDepartment of Medicine, Institute for Infectious Diseases, University of Bern , Bern, SwitzerlandDepartment of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern , Bern, SwitzerlandABSTRACT The antibacterial activity of 22 thiolato-bridged dinuclear ruthenium(II)-arene compounds was assessed in vitro against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. None of the compounds efficiently inhibited the growth of the three E. coli strains tested, and only compound 5 exhibited a medium activity against this bacterium [MIC (minimum inhibitory concentration) of 25 µM]. However, a significant antibacterial activity was observed against S. pneumoniae, with MIC values ranging from 1.3 to 2.6 µM for compounds 1–3, 5, and 6. Similarly, compounds 2, 5–7, and 20–22 had MIC values ranging from 2.5 to 5 µM against S. aureus. The tested diruthenium compounds have a bactericidal effect significantly faster than that of penicillin. Fluorescence microscopy assays performed on S. aureus using the BODIPY-tagged diruthenium complex 15 showed that this type of metal compound enters the bacteria and does not accumulate in the cell wall of gram-positive bacteria. Cellular internalization was further confirmed by inductively coupled plasma mass spectrometry experiments. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appears to significantly influence the antibacterial activity. Thus, if overall a decrease of the bactericidal effect with the increase of compounds’ molecular weight is observed, however, the complexes bearing larger benzo-fused lactam substituents had low MIC values. This first antibacterial activity screening demonstrated that the thiolato-diruthenium compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies. IMPORTANCE The in vitro assessment of diruthenium(II)-arene compounds against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus showed a significant antibacterial activity of some compounds against S. pneumoniae, with minimum inhibitory concentration (MIC) values ranging from 1.3 to 2.6 µM, and a medium activity against E. coli, with MIC of 25 µM. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appear to significantly influence the antibacterial activity. Fluorescence microscopy showed that these ruthenium compounds enter the bacteria and do not accumulate in the cell wall of gram-positive bacteria. These diruthenium(II)-arene compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies, especially the compounds bearing larger benzo-fused lactam substituents.https://journals.asm.org/doi/10.1128/spectrum.00954-23ruthenium complexesEscherichia coliStreptococcus pneumoniaeStaphylococcus aureusMICfluorescence
spellingShingle Quentin Bugnon
Camilo Melendez
Oksana Desiatkina
Louis Fayolles de Chaptes
Isabelle Holzer
Emilia Păunescu
Markus Hilty
Julien Furrer
In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds
Microbiology Spectrum
ruthenium complexes
Escherichia coli
Streptococcus pneumoniae
Staphylococcus aureus
MIC
fluorescence
title In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds
title_full In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds
title_fullStr In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds
title_full_unstemmed In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds
title_short In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds
title_sort in vitro antibacterial activity of dinuclear thiolato bridged ruthenium ii arene compounds
topic ruthenium complexes
Escherichia coli
Streptococcus pneumoniae
Staphylococcus aureus
MIC
fluorescence
url https://journals.asm.org/doi/10.1128/spectrum.00954-23
work_keys_str_mv AT quentinbugnon invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds
AT camilomelendez invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds
AT oksanadesiatkina invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds
AT louisfayollesdechaptes invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds
AT isabelleholzer invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds
AT emiliapaunescu invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds
AT markushilty invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds
AT julienfurrer invitroantibacterialactivityofdinuclearthiolatobridgedrutheniumiiarenecompounds